The Generic Sector Is A Complex Arena And The Stakes Are Rising

Dublin, Ireland - Research and Markets has announced the addition of Generic Handbook: A Guide to the US Generic Pharmaceutical Industry 2005 Edition to their offering.

At over 450 pages, GenericHandbook(TM) is a comprehensive, in-depth guide to the regulatory and judicial systems, market dynamics, products and companies in the US multi-source drug sector.

According to GenericHandbook's author, Todd Clark: The generic sector is an increasingly complex arena and the stakes are rising. Aggressive patent litigation, competition from low-cost providers in China and India, authorized generics, biogenerics and the Medicare Modernization Act are among the many factors that are changing the dynamics of this industry. The recently announced merger between leading companies Teva and Ivax is just one sign of the rapid developments taking place.

All of these subjects are covered extensively in GenericHandbook(TM). In addition, there is sales and marketing information on products losing patent protection over the next 5 years, the top 200 generic compounds and approximately 150 generic manufacturers.

There is no other publication that provides the same degree of depth, breadth and data on the multi-source drug industry in the United States.

Generic manufacturers, companies looking to expand their US presence, branded pharmaceutical executives seeking to defend their revenues, investors, intellectual property attorneys, consultants, researchers - in short, anyone whose business is affected by the US generic industry will benefit from the information and analysis in GenericHandbook.

For more information visit http://www.researchandmarkets.com/reports/c23691

SOURCE: Research and Markets